Marta Maglione

Dr. Marta Maglione

1. Institute for Biology/Genetics, Freie Universität Berlin, Berlin, Germany
+2

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Cell Reports
Verified
Journal Article
Open access
YLYongTian Liang
YongTian Liang
CPChengji Piao
Chengji Piao
CBChristine B. Beuschel
Christine B. Beuschel
DTDavid Toppe
David Toppe
LKLaxmikanth Kollipara
Laxmikanth Kollipara
SSStephan J. Sigrist
Stephan J. Sigrist
Mitochondrial function declines during brain aging and is suspected to play a key role in age-induced cognitive decline and neurodegeneration. Supplementing levels of spermidine, a body-endogenous metabolite, has been shown to promote mitochondrial respiration and delay aspects of brain aging. Spermidine serves as the amino-butyl group donor for the synthesis of hypusine (Nε-[4-amino-2-hydroxybutyl]-lysine) at a specific lysine residue of the eukaryotic translation initiation factor 5A (eIF5A). Here, we show that in the Drosophila brain, hypusinated eIF5A levels decline with age but can be boosted by dietary spermidine. Several genetic regimes of attenuating eIF5A hypusination all similarly affect brain mitochondrial respiration resembling age-typical mitochondrial decay and also provoke a premature aging of locomotion and memory formation in adult Drosophilae. eIF5A hypusination, conserved through all eukaryotes as an obviously critical effector of spermidine, might thus be an important diagnostic and therapeutic avenue in aspects of brain aging provoked by mitochondrial decline.

29 September 2016 in PLOS Biology
Verified
Journal Article
Open access
PDF file
VGVarun K. Gupta
Varun K. Gupta
UPUlrike Pech
Ulrike Pech
ABAnuradha Bhukel
Anuradha Bhukel
AFAndreas Fulterer
Andreas Fulterer
AEAnatoli Ender
Anatoli Ender
SSStephan J. Sigrist
Stephan J. Sigrist
Memories are assumed to be formed by sets of synapses changing their structural or functional performance. The efficacy of forming new memories declines with advancing age, but the synaptic changes underlying age-induced memory impairment remain poorly understood. Recently, we found spermidine feeding to specifically suppress age-dependent impairments in forming olfactory memories, providing a mean to search for synaptic changes involved in age-dependent memory impairment. Here, we show that a specific synaptic compartment, the presynaptic active zone (AZ), increases the size of its ultrastructural elaboration and releases significantly more synaptic vesicles with advancing age. These age-induced AZ changes, however, were fully suppressed by spermidine feeding. A genetically enforced enlargement of AZ scaffolds (four gene-copies of BRP) impaired memory formation in young animals. Thus, in the Drosophila nervous system, aging AZs seem to steer towards the upper limit of their operational range, limiting synaptic plasticity and contributing to impairment of memory formation. Spermidine feeding suppresses age-dependent memory impairment by counteracting these age-dependent changes directly at the synapse. Neurons communicate by sending impulses, in the form of secretion of neurotransmitters, across small spaces called synapses. It is these synapses that undergo structural and functional changes during formation and retrieval of memories. Though alterations in synaptic performance are believed to accompany aging, the causal relationship between age-dependent memory impairment and synaptic changes remains largely unknown. Using the fly Drosophila melanogaster as a model, we found that feeding them spermidine—a polyamine compound—suppresses age-induced decline in olfactory memory, providing us with a tool to further decipher mechanisms associated with age-dependent memory impairment. In this study, we investigated the relationship between synaptic changes and age-dependent memory impairment by studying the olfactory circuitry. We observed an age-related increase in the levels of the synaptic proteins Bruchpilot and Rim-binding protein, which caused an enlargement of the presynaptic active zone—the complex of proteins that mediate neurotransmitter release—and enhanced synaptic transmission. Interestingly, feeding of spermidine was sufficient to abolish these age-associated presynaptic changes, further emphasizing the relationship between presynaptic performance and age-dependent memory impairment. Furthermore, flies engineered to express an excess of the core active zone protein Bruchpilot showed a premature impairment in memory formation in young flies. Based on our data, aging plausibly steers the synapses towards the upper limit of their operational range, limiting synaptic plasticity and contributing to impairment of memory formation.

26 September 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MGM. Katharina Grauel
M. Katharina Grauel
Marta MaglioneMarta Maglione
Marta Maglione
SRSuneel Reddy-Alla
Suneel Reddy-Alla
CWClaudia G. Willmes
Claudia G. Willmes
MBMarisa M. Brockmann
Marisa M. Brockmann
CRChristian Rosenmund
Christian Rosenmund
Significance: Highly regulated and precise positioning of Ca 2+ channels at the active zone (AZ) controls Ca 2+ nanodomains at release sites. Their exact localization affects vesicular release probability (P VR ) and is important for proper synaptic transmission during repetitive stimulation. We provide a detailed analysis of synaptic transmission combined with superresolution imaging of the AZ organization in mouse hippocampal synapses lacking Rab-interacting molecule-binding protein 2 (RIM-BP2). By dual- and triple-channel time-gated stimulated emission depletion (gSTED) microscopy, we directly show that RIM-BP2 fine-tunes voltage-gated Ca 2+ channel 2.1 (Ca V 2.1) localization at the AZ. We reveal that RIM-BP2 likely regulates the Ca 2+ nanodomain by positioning Ca V 2.1 channels close to synaptic vesicle release sites. Loss of RIM-BP2 reduces P VR and alters short-term plasticity.

1 May 2019 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
MWMiranka Wirth
Miranka Wirth
CSClaudia Schwarz
Claudia Schwarz
GBGloria Benson
Gloria Benson
NHNora Horn
Nora Horn
RBRalph Buchert
Ralph Buchert
AFAgnes Flöel
Agnes Flöel
Background: Given the global increase in the aging population and age-related diseases, the promotion of healthy aging is one of the most crucial public health issues. This trial aims to contribute to the establishment of effective approaches to promote cognitive and brain health in older individuals with subjective cognitive decline (SCD). Presence of SCD is known to increase the risk of objective cognitive decline and progression to dementia due to Alzheimer’s disease. Therefore, it is our primary goal to determine whether spermidine supplementation has a positive impact on memory performance in this at-risk group, as compared with placebo. The secondary goal is to examine the effects of spermidine intake on other neuropsychological, behavioral, and physiological parameters.Methods: The SmartAge trial is a monocentric, randomized, double-blind, placebo-controlled phase IIb trial. The study will investigate 12 months of intervention with spermidine-based nutritional supplementation (target intervention) compared with 12 months of placebo intake (control intervention). We plan to recruit 100 cognitively normal older individuals with SCD from memory clinics, neurologists and general practitioners in private practice, and the general population. Participants will be allocated to one of the two study arms using blockwise randomization stratified by age and sex with a 1:1 allocation ratio. The primary outcome is the change in memory performance between baseline and post-intervention visits (12 months after baseline). Secondary outcomes include the change in memory performance from baseline to follow-up assessment (18 months after baseline), as well as changes in neurocognitive, behavioral, and physiological parameters (including blood and neuroimaging biomarkers), assessed at baseline and post-intervention.Discussion: The SmartAge trial aims to provide evidence of the impact of spermidine supplementation on memory performance in older individuals with SCD. In addition, we will identify possible neurophysiological mechanisms of action underlying the anticipated cognitive benefits. Overall, this trial will contribute to the establishment of nutrition intervention in the prevention of Alzheimer’s disease.Trial registration: ClinicalTrials.gov,NCT03094546. Registered 29 March 2017—retrospectively registered.Protocol version: Based on EA1/250/16 version 1.5

23 February 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RFRyota Fukaya
Ryota Fukaya
Marta MaglioneMarta Maglione
Marta Maglione
SSStephan J. Sigrist
Stephan J. Sigrist
TSTakeshi Sakaba
Takeshi Sakaba
Significance: Despite the importance of the activation of the cAMP/PKA signaling pathway for presynaptic modulation, its cellular and molecular mechanisms remain unclear. In this study, we tackled this issue at hippocampal mossy fiber-CA3 synapses by combining paired electrophysiological recordings, Ca 2+ uncaging, total internal reflection fluorescence (TIRF) microscopy for direct measurements of presynaptic active zone Ca 2+ influx, and superresolution time-gated STED microscopy for visualization of Ca 2+ channel clusters within active zones. Our results suggest that Ca 2+ channels near release sites might accumulate upon activation of the cAMP/PKA pathway in the time scale of only several minutes. Our findings may thus change the focus from release machinery to Ca 2+ channel clusters and their dynamics as a cell biological mechanism of cAMP-dependent synaptic modulation.

26 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
APAtefeh Pooryasin
Atefeh Pooryasin
Marta MaglioneMarta Maglione
Marta Maglione
MSMarco Schubert
Marco Schubert
TMTanja Matkovic-Rachid
Tanja Matkovic-Rachid
SHSayed-Mohammad Hasheminasab
Sayed-Mohammad Hasheminasab
SSStephan J. Sigrist
Stephan J. Sigrist
The physical distance between presynaptic Ca2+ channels and the Ca2+ sensors triggering the release of neurotransmitter-containing vesicles regulates short-term plasticity (STP). While STP is highly diversified across synapse types, the computational and behavioral relevance of this diversity remains unclear. In the Drosophila brain, at nanoscale level, we can distinguish distinct coupling distances between Ca2+ channels and the (m)unc13 family priming factors, Unc13A and Unc13B. Importantly, coupling distance defines release components with distinct STP characteristics. Here, we show that while Unc13A and Unc13B both contribute to synaptic signalling, they play distinct roles in neural decoding of olfactory information at excitatory projection neuron (ePN) output synapses. Unc13A clusters closer to Ca2+ channels than Unc13B, specifically promoting fast phasic signal transfer. Reduction of Unc13A in ePNs attenuates responses to both aversive and appetitive stimuli, while reduction of Unc13B provokes a general shift towards appetitive values. Collectively, we provide direct genetic evidence that release components of distinct nanoscopic coupling distances differentially control STP to play distinct roles in neural decoding of sensory information.